The Vice President of Drug Development Portfolio Strategy will lead disease strategy development and prioritization of investment across Oncology, Hematology/Cell Therapy, Cardiovascular Disease, Immunology, and Neuroscience for drug development. This role will be responsible for developing data-driven objective frameworks to drive decisions on drug development portfolio budget across diseases connected to therapeutic area and enterprise strategy. This role will play a pivotal part in guiding investments toward the most promising science in areas where BMS holds an industry-leading position.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive
Education Level
Ph.D. or professional degree
Number of Employees
5,001-10,000 employees